no icon
no icon
amc icon

Hdfc Pharma And Healthcare Fund - Growth Option - Direct Plan

Equity | Sector Specific - Pharma

(NAV as of 17/05/2024)
12.78 (-0.16)

3Y Returns

NA

Min SIP

100

Min Lumpsum

100

Expense Ratio

1.26%

Fund Size

648 Cr

Inception Date

28-Sep-23

Fund Manager

Nikhil Mathur

Exit Load

1% on or before 30D, Nil after 30D.

Wealthzi View

Overall Fund Zi Tag

Asset Allocation

Equity

98.67%

Debt & Others

1.33%

Market Cap Allocation

Large Cap

35.53%

Mid Cap

33.10%

Small Cap

30.05%

Other Cap

1.33%

Sector Allocation

Pharmaceuticals

69.94%

Health Care

27.36%

Insurance

1.01%

Retailing

0.75%

Cash/Deposits/Margins/Treps/Repo/Swaps

0.52%

Top Ten Holdings

Sun Pharmaceutical Industries Ltd

11.09%

Cipla Ltd

7.71%

Dr. Reddy'S Laboratories Ltd

6.69%

Lupin Ltd

4.89%

Ajanta Pharma Ltd

4.40%

Investment Objective

To Provide Long-Term Capital Appreciation By Investing Predominantly In Equity And Equity Related Securities Of Pharma And Healthcare Companies.

Fund House Detail

AMC Name

HDFC Asset Management Company Limited

Address

HDFC House, 2nd floor, H.T. Parekh Marg,165-166 Backbay Reclamation, ChurchgateMumbai - 400 020

BUILD WEALTH WITH CONFIDENCE

no iconno iconno iconno icon
no icon

BSE Member code: 58371

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
get on play storeget on app store

Wealthzi Investment Advisers (A division of Lime Internet Private Limited)

[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]

[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sahad PV, Email: [email protected]]

[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]

Disclaimers:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The information is only for consumption by the client and such material should not be redistributed.